The identification of VPS highlights the need for continued monitoring of vaccine-related adverse events. It also highlights the importance of transparency in communicating potential risks to maintain public confidence in vaccination programmes.

Although post-vaccination syndrome is a reality for some individuals, it remains a rare condition. The benefits of mRNA COVID-19 vaccines, in terms of preventing severe disease and reducing mortality, far outweigh the potential risks. However, recognition and careful study of these rare adverse events are essential to improve vaccine safety and provide appropriate support to those affected.